REFERENCES
- Hardy WR, Anderson RE: The hypereosinophilic syndrome. Ann Int Med 68: 120–128, 1968.
- Chusid MJ, Dale DC, West BC et al.: The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine 54: 1–27, 1975.
- Schooley RT, Flaum MA, Gralnick HR et al: A clinicopathologic correlation of the idiopathic hypereosinophilic syndrome. II. Clinical manifestations Blood 58: 1021–1026, 1981.
- Fauci AS, Harley JB, Roberts WC et al.: The idiopathic hypereosinophilic syndrome: clinical pathophysiologic and therapeutic considerations. Ann Intern Med 97: 78–92, 5982.
- Spry CJF, Davies J, Tai PC et al: Clinical features of fifteen patients with the hypereosinophilic syndrome. Q J Med 52: 1–22, 1983.
- Weller PF, Bubley GJ: The idiopathic hypereosinophilic syndrome. Blood 83: 2759–2779, 1994.
- Koike R, Yoshida S: A case of idiopathic hypereosinophilic syndrome (HES) complicated by pulmonary infarction. Arerugi 40: 1232–1238, 1991 (in Japanese).
- Suenaga N, Hayashi F, Miyauchi N et al: A case of hypereosinophilic syndrome associated with pulmonary infarction and hepatic vein obstruction (Budd-Chian syndrome). Nippon-Kyoubu-Shikkan-Gakkai-Zasshi 29: 239–244, 1991 (in Japanese).
- Fujiwara Y, Yamanashi K, Nishiura Y et al: A case of pulmonary infarction associated with severe hypereosinophilia. Nippon-Naika-Gakkai-Zasshi 76: 1312, 1987 (in Japanese).
- Ishii T, Koide O, Hosoda Y et al: Hypereosinophilic multiple thrombosis. Angiology 28: 361–375, 1977.
- Yamamoto H, Ninomiya H, Yoshimatsu K et al: Serum levels of major basic protein in patients with or without eosinophilia: measurement by enzyme-linked immunosorbent assay. Br J Haematol 86: 490–495, 1994.
- Venge P, Dahl R, Hallgren R: Enhancement of factor XII dependent reactions by eosinophil cationic protein. Thrombosis Res 14: 641–649, 1997.
- Hanowell ST, Kim YD, Rattan V et al: Increased heparin requirement with hypereosinophilic syndrome. Anesthesiology 55: 450–452, 1987.
- Costa JJ, Matossian K, Resnick MB el al: Human eosinophils can express the cytokines tumor necrosis factor-^ and macrophage inflammatory protein-la. J Clin Invest 91: 2673–2684, 1993.
- Tai P-C, Ackerman SJ, Spry CJF et al: Deposits of eosinophilic granule proteins in cardiac tissues on patients with eosinophilic endomyocardial disease. Lancet i: 643–647, 1987.
- Ohashi H, Goto Y, Shimomura N et al: Venous thrombosis in two patients with hypereosinophilic syndrome. Skiz.uoka-ken Rinshoumeneki Ktmwakai Kirahu 15: 3–7, 1992 (in Japanese).
- Liesveld JL, Abboud CN: State of the art: the hypereosinophilic syndrome. Blood Rev 5: 29–37, 1991.
- Schrezenmeier H, Thomé SD, Tewald F et al: Interleukin-5 is the predominant eosinophilopoietin produced by cloned T lymphocytes in hypereosinophilic syndrome. Exp Hematol 21: 358–365, 1993.
- Satoh T, Sun I, Li M-S et al.: Interleukin-5 mRNA levels in blood and bone marrow mononuclear cells from patients with the idiopathic hypereosinophilic syndrome. Immunology 83: 308–312, 1994.
- Cogan E, Scliandené L, Crusiaux A et al: Clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome. N Eng J Med 330: 535–538, 1994.